| CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
GPR12 |
GPR12: Probable G-protein coupled receptor 12 |
0.745 |
Evidence |
|
| LTBR |
LTBR, D12S370, TNFCR, TNFRSF3: Tumor necrosis factor receptor superfamily member |
TNFRSF19 |
TNFRSF19, TAJ, UNQ1888/PRO4333, TROY: Tumor necrosis factor receptor superfamily |
0.745 |
Evidence |
|
| IRS1 |
IRS1: Insulin receptor substrate 1 |
PPFIA1 |
PPFIA1, LIP1: Liprin-alpha-1 |
0.745 |
Evidence |
|
| DRD3 |
DRD3: D(3) dopamine receptor |
EDG8 |
EDG8: Sphingosine 1-phosphate receptor Edg-8 |
0.745 |
Evidence |
|
| DRD3 |
DRD3: D(3) dopamine receptor |
GPR88 |
GPR88, STRG: Probable G-protein coupled receptor 88 |
0.745 |
Evidence |
|
| DRD3 |
DRD3: D(3) dopamine receptor |
C9orf47 |
EDG3: Sphingosine 1-phosphate receptor Edg-3 |
0.745 |
Evidence |
|
| DRD3 |
DRD3: D(3) dopamine receptor |
CCR8 |
CCR8, CKRL1, CMKBR8, CMKBRL2: C-C chemokine receptor type 8 |
0.745 |
Evidence |
|
| DRD3 |
DRD3: D(3) dopamine receptor |
XCR1 |
XCR1, CCXCR1, GPR5: Chemokine XC receptor 1 |
0.745 |
Evidence |
|
| DRD3 |
DRD3: D(3) dopamine receptor |
GPR1 |
GPR1: Probable G-protein coupled receptor 1 |
0.745 |
Evidence |
|
| MAS1L |
MAS1L, MRG: Mas-related G-protein coupled receptor MRG |
CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
0.745 |
Evidence |
|
| HRH1 |
HRH1: Histamine H1 receptor |
OR2C3 |
Olfactory receptor OR1-30 |
0.745 |
Evidence |
|
| ADRA1A |
ADRA1A, ADRA1C: Alpha-1A adrenergic receptor |
NMUR2 |
NMUR2, NMU2R, TGR1: Neuromedin-U receptor 2 |
0.745 |
Evidence |
|
| ADRA1A |
ADRA1A, ADRA1C: Alpha-1A adrenergic receptor |
OR11A1 |
OR11A1, OR11A2: Olfactory receptor 11A1 |
0.745 |
Evidence |
|
| ADRA1A |
ADRA1A, ADRA1C: Alpha-1A adrenergic receptor |
P2RY8 |
P2RY8: P2Y purinoceptor 8 |
0.745 |
Evidence |
|
| ADRA1A |
ADRA1A, ADRA1C: Alpha-1A adrenergic receptor |
CCR9 |
IPI00019986 |
0.745 |
Evidence |
|
| SSTR5 |
SSTR5: Somatostatin receptor type 5 |
GPR34 |
GPR34: Probable G-protein coupled receptor 34 |
0.745 |
Evidence |
|
| SSTR5 |
SSTR5: Somatostatin receptor type 5 |
GPR141 |
GPR141, PGR13: Probable G-protein coupled receptor 141 |
0.745 |
Evidence |
|
| SSTR5 |
SSTR5: Somatostatin receptor type 5 |
GPR142 |
GPR142, PGR2: Probable G-protein coupled receptor 142 |
0.745 |
Evidence |
|
| SSTR5 |
SSTR5: Somatostatin receptor type 5 |
GPR162 |
GPR162, GRCA: Probable G-protein coupled receptor 162 |
0.745 |
Evidence |
|
| NF2 |
NF2, SCH: Merlin |
TAX1BP3 |
TAX1BP3, TIP1: Tax1-binding protein 3 |
0.745 |
Evidence |
|
| NF2 |
NF2, SCH: Merlin |
RANBP3 |
RANBP3: Ran-binding protein 3 |
0.745 |
Evidence |
|
| PTGER1 |
PTGER1: Prostaglandin E2 receptor EP1 subtype |
CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
0.745 |
Evidence |
|
| OR1D2 |
OR1D2, OLFR1: Olfactory receptor 1D2 |
GPR62 |
GPR62: Probable G-protein coupled receptor 62 |
0.745 |
Evidence |
|
| OR1D2 |
OR1D2, OLFR1: Olfactory receptor 1D2 |
C3AR1 |
C3AR1, AZ3B, C3R1, HNFAG09: C3a anaphylatoxin chemotactic receptor |
0.745 |
Evidence |
|
| CNR2 |
CNR2: Cannabinoid receptor 2 |
OR1A2 |
OR1A2: Olfactory receptor 1A2 |
0.745 |
Evidence |
|